About
Dr Yasser Falah
Consultant Neurologist
MBChB, MRCP (UK), MRCP Neurology, PhD
Dr Falah is a Consultant Neurologist based in London. He completed his postgraduate training and PhD degree in the UK. He is appointed by King’s College Hospital. He is a visiting senior clinical lecturer at King’s College London. He has expertise in all aspects of neurology.
Professional Qualifications
PhD in Clinical Neurology, University of Nottingham, UK (2019)
Certificate of completion of training (CCT) in Neurology, West Midlands Deanery, UK (2019)
Specialty Certificate Examination (SCE) in Neurology, Royal College of Physicians, UK (2013)
MRCP (UK), Royal College of Physicians, London, UK (2011)
MBChB, College of Medicine, Baghdad University, Baghdad, Iraq (2005)
Academic Distinctions, Awards, Honours & Prizes
Top 20 downloaded papers in 2017, Journal of Neuroimaging (The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T).
Mason Medical Research Trust Grant Award (£9000), Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome.
Excellence in Clinical Teaching Award, nominated by Keele University Medical students as an excellent clinical teacher, Academic Year 2012-2013, Royal Stoke University Hospital, Stoke-on-Trent.
Research Experience
I completed my PhD in Clinical Neurology at the University of Nottingham in 2019. My research was focused on use of perfusion MRI in neurological disorders. I am currently involved in multiple sclerosis trials at King’s College Hospital. I take part in the UK MS Trials and Registries network group.
Publications
Current appointments
November 2022 – Present: Consultant Neurologist, Lyca Health, Orpington, London, UK
September 2022 – Present: Consultant Neurologist, Guthrie Clinic, King’s College Hospital, London, UK
July 2022 – Present: Visiting Senior Clinical Lecturer, King’s College London, UK
September 2021 – Present: Consultant Neurologist, King’s College Hospital, London, UK
Previous appointments
September 2019 – August 2021: Consultant Neurologist, Nottingham University Hospitals, UK
September 2019 – August 2021: Consultant Neurologist, University Hospitals of Leicester, UK
February 2015 – January 2018: Research Neurology Registrar, Academic Neurology Department, University of Nottingham, UK
August 2011 – July 2019: Clinical Neurology Registrar, West Midlands rotation, UK
July 2007 – August 2011: Foundation and General Medical Training, West and East Midlands rotations, UK
i. Radu Tanasescu, Christopher R. Tench, Cris S. Constantinescu, Gary Telford, Sonika Singh, Nanci Frakich, David Onion, Dorothee P. Auer, Bruno Gran, Nikos Evangelou, Yasser Falah et al, “Hookworm Treatment for Relapsing Multiple Sclerosis A Randomized Double-Blinded Placebo-Controlled Trial”. JAMA Neurol. 2020;77(9):1089-1098. doi:10.1001/jamaneurol.2020.1118.
ii. Margareta A Clarke , Amal PR Samaraweera, Yasser Falah et al, “Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty”. Multiple Sclerosis Journal. 2020 Apr;26(4):433-441. doi: 10.1177/1352458519882282. Epub 2019 Oct 31. PMID: 31668125.
iii. Richard J. Dury*, Yasser Falah* et al, “Ultra-high-field arterial spin labelling MRI for non-contrast assessment of cortical lesion perfusion in multiple sclerosis”. European Radiology (2019) 29: 2027. https://doi.org/10.1007/s00330-018-5707-5 (*joint first authorship).
iv. Amal P.R. Samaraweera, Yasser Falah et al, “The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD”. Neurol Neuroimmunol Neuroinflamm 2018;5:e496.
v. Samaraweera AP, Clarke MA, Whitehead A, Falah Y et al, “The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T”. J Neuroimaging, 2017 Jan;27(1):114-121.
vi. Falah Y, Al-Araji A, “Multiple Sclerosis in Iraq: History, Epidemiology and the Future”. TOFIQ Journal of Medical Sciences, November 2014. TJMS 1(1):62-68.
vii. Falah Y, “Secondary Progressive Multiple Sclerosis: What is in the Horizon?”. J Neurol Transl Neurosci 2(2):1046. February 2014.
viii. Falah Y, Al-Araji A, “Neuro-Behçet’s disease”. EPub www.ebrainjnc.com, an educational website led by the Joint Neurosciences Council (JNC). November 2011.
Professional
Affiliations
Member of the Association of British Neurologists, membership no. 1858.
Collegiate member of the Royal College of Physicians London, membership no. 143984.
